Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News LAMELEE IRON ORE LTD V.LIR

Metals & Mining Industrial Metals & Minerals
"Lamelee Iron Ore Ltd is a mineral exploration company. It is engaged in exploration and development of mineral assets. The company owns an interest in several mining claims on the Meston Lake West Property, located in Chibougamau, Quebec."

Recent & Breaking News (TSXV:LIR)

PharmaDrug Announces Appointment of Auditor

Newsfile August 6, 2021

PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease

Newsfile August 5, 2021

Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers

Newsfile July 28, 2021

PharmaDrug Announces Stock Ticker Symbol Change to (CSE: PHRX)

Newsfile July 23, 2021

PharmaDrug Reports Positive Preclinical Study Results of Cepharanthine to Treat Cancers

Newsfile July 14, 2021

PharmaDrug Announces Change of Auditor

Newsfile July 12, 2021

PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Infectious Diseases Including COVID-19

Newsfile June 22, 2021

Pharmadrug's Supersmart Launches Psilocybin Online Retail Platform in the Netherlands

Newsfile June 7, 2021

PharmaDrug's Super Smart Launches Online Retail Platform in the United States

Newsfile May 17, 2021

PharmaDrug Signs Supply Agreement with European Cannabis Extractor for Medical Grade THC Oil to Be Sold Under PharmaDrug Brand

Newsfile May 14, 2021

PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and Grants Him Options and Promotes Him to Chief Scientific Officer for All of Pharmadrug

Newsfile May 13, 2021

PharmaDrug Initiates Preclinical Study of Cepharanthine to Both Broaden Its Cancer Scope and to Streamline Its Strategy for Esophageal Cancer

Newsfile May 6, 2021

PharmaDrug Announces First FDA Orphan Drug Designation of DMT for the Prevention of Ischemia-Reperfusion Injury from Organ Transplantation

Newsfile April 28, 2021

PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Rare Cancers and Infectious Diseases

Newsfile April 20, 2021

Pharmadrug Initiates DMT Research Activities via Collaboration with the University of Michigan for Foundational DMT Research Study

Newsfile March 16, 2021

PharmaDrug Provides Update on Its Annual General Meeting

Newsfile March 12, 2021

PharmaDrug Announces Drug-Repurposing Expert Moshe Rogosnitzky Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board

Newsfile March 9, 2021

PharmaDrug Announces World-Renowned Gastric Cancer Expert Dr. Yelena Y. Janjigian Joins Sairiyo Therapeutics Scientific and Clinical Advisory Board

Newsfile March 4, 2021

PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics Strategy

Newsfile February 25, 2021

PharmaDrug Files for FDA Orphan Drug Designation for DMT in Stroke

Newsfile February 11, 2021